StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite
Stock Guru Profile News Blogs Download MP3 Audio: http://www.stockguru.com/audio/sout10022007.mp3 Download Windows Media: http://www.stockguru.com/audio/sout10022007.wma Rx Elite’s Sevoflurane marketing plan is well underway. Jonathan Houssian, President and Founder of Rx Elite explain in his interview with Talking Stocks that sevoflurane as a generic inhalable gas will not see a strong price erosion. (Reminder: Sevoflurane is the most widely used inhalable gas anesthesia in the world and RxElite is one of only three distributors in the United States.) Why? There are only three manufacturers of Sevoflurane in the world. Why? The process by which Sevoflurane is manufactured is expensive, complex, and it takes…